Structures by: Jing L. L.
Total: 13
4,4,5,5-Tetramethyl-2-(3,4,5-trimethoxyphenyl)imidazolidine-1-oxyl 3-oxide
C16H23N2O5
Acta Crystallographica Section E (2009) 65, 9 o2090
a=20.623(3)Å b=7.2168(12)Å c=22.831(4)Å
α=90.00° β=90.00° γ=90.00°
(<i>R</i>)-2-[1-(2,6-Dichloro-3,4,5-trimethoxybenzoyl)pyrrolidin-2-yl]-\ 4,4,5,5-tetramethyl-4,5-dihydro-1<i>H</i>-imidazole-1-oxyl 3-oxide
C21H28Cl2N3O6
Acta Crystallographica Section E (2011) 67, 4 o985-o986
a=10.975(2)Å b=12.255(3)Å c=17.741(4)Å
α=90.00° β=90.00° γ=90.00°
2-(1<i>H</i>-Indol-3-yl)-4,4,5,5-tetramethylimidazolidine-1-oxyl 3-oxide
C15H18N3O2
Acta Crystallographica Section E (2010) 66, 2 o428
a=15.0810(15)Å b=8.7700(8)Å c=10.6108(10)Å
α=90.00° β=90.00° γ=90.00°
2-[1-(4-Chlorobenzoyl)pyrrolidin-2-yl]-4,4,5,5-tetramethyl-4,5- dihydroimidazole-1-oxyl-3-oxide
C18H23ClN3O3
Acta Crystallographica Section E (2011) 67, 2 o425
a=11.6202(19)Å b=8.2694(13)Å c=20.315(3)Å
α=90.00° β=105.636(2)° γ=90.00°
Triphenylphosphine oxide--2-(4-hydroxybenzenyl)-4,4,5,5-tetramethylimidazolidine-1-oxyl 3-oxide (1/1)
C18H15OP,C13H17N2O3
Acta Crystallographica Section E (2009) 65, 10 o2444
a=8.8431(11)Å b=12.0786(15)Å c=13.9649(16)Å
α=86.386(2)° β=82.724(2)° γ=77.318(2)°
3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate
C20H22N2O6
Acta Crystallographica Section E (2010) 66, 1 o86
a=8.4222(9)Å b=16.5850(16)Å c=14.5011(15)Å
α=90.00° β=102.748(2)° γ=90.00°
1-Methyl-1,2,3,4-tetrahydrocarbolin-2-ium-3-carboxylate
C13H14N2O2
Acta Crystallographica Section E (2010) 66, 2 o446
a=4.9772(8)Å b=14.520(2)Å c=15.307(2)Å
α=90.00° β=90.00° γ=90.00°
2-[1-(<i>tert</i>-Butoxycarbonyl)pyrrolidin-2-yl]-4,4,5,5-tetramethyl-4,5- dihydro-1<i>H</i>-imidazole-1-oxyl 3-oxide
C16H28N3O4
Acta Crystallographica Section E (2010) 66, 8 o1954
a=6.1016(12)Å b=10.392(2)Å c=14.488(3)Å
α=90.00° β=101.312(3)° γ=90.00°
5,6-Dihydroxy-7,8-dimethoxyflavone
C17H14O6
Acta Crystallographica Section E (2013) 69, 7 o1096
a=7.953(6)Å b=8.548(6)Å c=10.951(8)Å
α=96.602(8)° β=92.282(8)° γ=100.279(7)°
2-[4-(2-Hydroxyethoxy)phenyl]-4,4,5,5-tetramethyl-2-imidazoline-1-oxyl 3-oxide
C15H21N2O4
Acta Crystallographica Section E (2011) 67, 12 o3348
a=8.869(3)Å b=16.050(5)Å c=20.925(6)Å
α=90.00° β=90.00° γ=90.00°
2-[2-(2-Hydroxyethoxy)phenyl]-4,4,5,5-tetramethyl-2-imidazoline-1-oxyl 3-oxide
C15H21N2O4
Acta Crystallographica Section E (2011) 67, 12 o3503
a=14.458(7)Å b=10.187(5)Å c=10.670(5)Å
α=90.00° β=90.00° γ=90.00°
Methyl 2-{[2-(4,4,5,5-tetramethyl-1,3-dioxyl- 4,5-dihydroimidazol-2-yl)phenyl]oxy}acetate
C16H21N2O5
Acta Crystallographica Section E (2012) 68, 1 o217
a=11.421(6)Å b=7.381(4)Å c=19.700(11)Å
α=90.00° β=91.832(6)° γ=90.00°
2-[3-Hydroxy-4-(2-hydroxyethoxy)phenyl]-4,4,5,5-tetramethyl-2-imidazoline-1-oxyl 3-oxide
C15H21N2O5
Acta Crystallographica Section E (2012) 68, 1 o218
a=9.787(4)Å b=9.302(3)Å c=16.657(6)Å
α=90.00° β=93.525(3)° γ=90.00°